Education
About Us
Working with TipRanks
Follow Us
Conduit Pharmaceuticals Inc. (CDT)
:CDT
CDT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.57 - $275.17
Previous Close$0.08
Volume254.55M
Average Volume (3M)8.33M
Market Cap
$2.75M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.51
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-21.28
Shares Outstanding3,062,025
10 Day Avg. Volume24,690,795
30 Day Avg. Volume8,334,801
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Conduit Pharmaceuticals News
CDT FAQ
What was Conduit Pharmaceuticals Inc.’s price range in the past 12 months?
Conduit Pharmaceuticals Inc. lowest stock price was $0.57 and its highest was $275.17 in the past 12 months.
What is Conduit Pharmaceuticals Inc.’s market cap?
Conduit Pharmaceuticals Inc.’s market cap is $2.75M.
When is Conduit Pharmaceuticals Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Conduit Pharmaceuticals Inc.’s earnings last quarter?
Currently, no data Available
Is Conduit Pharmaceuticals Inc. overvalued?
According to Wall Street analysts Conduit Pharmaceuticals Inc.’s price is currently Overvalued.
Does Conduit Pharmaceuticals Inc. pay dividends?
Conduit Pharmaceuticals Inc. does not currently pay dividends.
What is Conduit Pharmaceuticals Inc.’s EPS estimate?
Conduit Pharmaceuticals Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Conduit Pharmaceuticals Inc. have?
Conduit Pharmaceuticals Inc. has 3,062,025 shares outstanding.
What happened to Conduit Pharmaceuticals Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Conduit Pharmaceuticals Inc.?
Currently, no hedge funds are holding shares in CDT
Conduit Pharmaceuticals Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 1.0 Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 11.7%
Last 30 Days ▲ 14.4%
Last 30 Days ▲ 14.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
141.72%
Trailing 12-Months
Company Description
Conduit Pharmaceuticals Inc.
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
Conduit Pharmaceuticals (CDT) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Matinas BioPharma
―
Quoin Pharmaceuticals
―
Silo Pharma
―
CNS Pharmaceuticals
―
Galecto
―
Ownership Overview
58.94% Insiders
0.07% Mutual Funds
0.07% Other Institutional Investors
40.95% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---